Novartis AG (NVS) stock
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.20−0.30 (-0.19%)
Close on Nov 16, 2026Market cap $305.69BP/E 22.4Yield –
Novartis market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Novartis's market cap was $319.17B on Nov 10, 2026, against $265.36B a year earlier. Over the last 5 years it ranged from $171.78B to $321.75B, with a median of $220.75B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $319.17B | +13.8% |
| 2025 | Dec 31, 2025 | $280.57B | +37.8% |
| 2024 | Dec 31, 2024 | $203.57B | -8.2% |
| 2023 | Dec 29, 2023 | $221.83B | +8.2% |
| 2022 | Dec 30, 2022 | $205.03B | +2.1% |
| 2021 | Dec 31, 2021 | $200.83B | -8.3% |
| 2020 | Dec 31, 2020 | $218.98B | -1.3% |
| 2019 | Dec 31, 2019 | $221.95B | +11.4% |
| 2018 | Dec 31, 2018 | $199.23B | -0.0% |
| 2017 | Dec 29, 2017 | $199.33B | +15.3% |
| 2016 | Dec 30, 2016 | $172.91B | -16.2% |
| 2015 | Dec 31, 2015 | $206.38B | – |
See a number that looks wrong?